chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Headache and notable fatigue lasting 3+ hours, occurring 24 hours after vaccine received. Headache relieved by acetaminophen 500mg, fatigue not relieved at time of report (4 hours after onset).
Swollen lymph nodes under armpit - same side as vaccine Migraine Fever Body aches Congestion Nausea
8/28 immediately upon administration of Tdap Pt. expressed pain & arm felt numb, hot & full from shoulder to hand & into the muscle. Through out day her arm was sore but could move it, 8/29 arm more difficult to move in morning. On 8/30 & 8/31 arm was "so-so". On 9/1 it hurt and 9/2 had problem lifting arm & can't feel pressure on arm. 9/4 continues to be unable to lift arm. Has medical appt. 9/4/12 in afternoon.
loss of control, arthritis in hand, feet, elbow, neck, ankles, fever, loss of appetite, dizziness;almost passing out, partial rash on chest;
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 60-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 15Jul2022 as dose 4 (booster), single (Lot number: FM0173) at the age of 59 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Osteoporosis" (unspecified if ongoing); "hypothyroidism" (unspecified if ongoing); "anxiety" (unspecified if ongoing). Concomitant medication(s) included: LEXAPRO, start date: 15Mar2002; LEVOTHYROXINE, start date: 15Jan2000; VITAMIN D [COLECALCIFEROL], start date: 15Jan2020. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Dec2022, outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Dec2022) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19 with paxlovid from 19Dec2022 to 23Dec2022.  Clinical Course: Patient was taking other medications/products within 2 weeks of starting COVID-19 treatment. Patient previously received a COVID-19 Vaccine.   No follow-up attempts are possible. No further information is expected.; Sender's Comments: Based on available information and the temporal association, a possible contributory role of Comirnaty vaccine cannot be excluded for the reported events of "DRUG INEFFECTIVE " and "COVID-19 .
Information has been received from a physician concerning an 8 year old female pt who was vaccinated with a 1st and 2nd dose of MMR, on 6/3/92 and 2/23/96. On 8/6/99, the pt developed mumps. Subsequently, the pt recovered. Additional information has been requested.
Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Lymphoma (non-Hodgkin's) (Non Hodgkin's Lymphoma).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever). At the time of the report, PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided.  No treatment medications were provided.
Raynauds Syndrome started in 7 days - ongoing currently Bilateral Carpal Tunnel - 90 days after 2nd injection (2/26/2021)
Cellulitis: Original therapy due to be Clindamycin. Dr. will be changing to another antibiotic.
Pfizer-BioNTech COVID-19 Vaccine EUA The first symptoms to appear at  approximately 8:00 pm on Feb. 9th the day of my mom?s vaccine were headache and diarrhea.  The following day, 2/10 she seemed to feel better and went on with her day.  The night of 2/10 she awoke coughing and wheezing.  She called 911 at approximately 4:45 am on 2/11.  They transported her to hospital.
This was my second booster - all shots Moderna. This morning I have painful swollen Lymph node(s) under my left jaw. Quite visible difference from left to right jaw.   Yesterday I was exhausted - better today. Pain and swelling at vaccination site.
4 to 6 hours after I received the vaccine I started with a hive like rash. It wasn't very itchy until the next day. The hives started on the back of my right arm. I did a virtual visit with my doctor and he told me to take OTC antihistamine and use hydrocortisone cream. The itching and rash still spread so I went to the ER. They gave me a steroid injection on my left side. I was prescribed Methylprednisolone 4mg and Hydroxyzine HCL 25mg. The rash is now controlled, but the itching is still continuous. The hives are going away.
Raised, red, warm rash at site of injection. About 2-3 inches in diameter. Starting 7 days after vaccination (2nd dose). Child complains of pain and tenderness at the site.
little low on potassium; migraine/migraine headaches/migraine hurt so bad; This is a spontaneous report from a contactable consumer (patient). A 48-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered in the left arm (reported as left shoulder) on 16Jul2021 13:00 (Batch/Lot Number: FA6780; Expiration Date: 2021 (reported as Aug2021 or Sep2021) (at the age of 48-year-old) as dose 1, single for COVID-19 immunization. The vaccination facility type was pharmacy/drug store. The patient had no previous immunization with BNT162B2. There were no other vaccines administered on same date with BNT162B2. The patient did not receive any other vaccinations within four weeks prior to the first administration date of BNT162B2. The patient had no medical history (as reported). Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL; reported as Adderall Extended Release) taken for an unspecified indication from an unspecified start date and ongoing; fluoxetine (FLUOXETINE) taken for an unspecified indication from an unspecified start date and ongoing; both taken by the patient for about 10 years. The patient reported that she received her first dose of the Pfizer COVID-19 vaccine on 16Jul2021 and she developed a migraine that would not go away so she got scared and went to the ER on she thinks 26Jul2021. She stated that she never really gets migraines. In the ER, she had a CAT Scan and blood work and she did not have a blood clot. She was given medication thru her IV which helped but felt better for a day or so and now they migraines were back. She was wondering if this has been reported and how long was it going to last for. The patient reported that she received the first dose of the Covid 19 vaccine on 16Jul2021. She didn't have any side effects for 2 days, but after those 2 days (18Jul2021), she developed migraine headaches. She's never had migraines before, and she ended up in the emergency department because the migraine hurt so bad. The patient asked how long these migraines should last and if it was something that was being reported. Her headaches started on 18Jul2021 or 19Jul2021. She went to the emergency department on 26Jul2021. She had a CT scan and a blood draw. The CT scan came back that she was fine. For her blood draw, she was a little low on potassium but everything else was in range. In the emergency department she was given something in her IV to cure the migraine and she was good for about a day. Now the migraines were back, and they were persisting. The outcome of migraine/migraine headaches was not recovered. The outcome of low potassium was unknown.
Patient received a dose / only with the diluent component; Patient received a dose / only with the diluent component; This case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a 67-year-old male patient who received Herpes zoster (Shingrix) (batch number P2J7E, expiry date 10th October 2022) for prophylaxis.   On 9th April 2021, the patient received Shingrix. On 9th April 2021, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.  Additional details were provided as follows: Pharmacist reported that a patient received a dose of Shingrix only with the diluent component (without the powder portion), which led to inappropriate dose of vaccine administered. The reporter consent to follow up.
Received the Moderna Pediatric (6-11yrs) dose instead of the Moderna updated booster
Information was received 05-JUL-2017 via a phone call from a nurse who reported that an unknown number of patients (names and other demographics unknown to the reporter) were vaccinated with VARIVAX that had undergone a temperature excursion.  Administration dates were unspecified. The following VARIVAX lot numbers underwent the temperature excursion of 6 degrees F to 14 degrees F (-14 degrees C to -10 degrees C)  (-11 degrees C) for 144 minutes:  Lot M042495 Expiration 19-OCT-2018, Lot M046924 Expiration 28-NOV-2018, Lot M047662 Expiration 02-DEC-2018, Lot N014368 Expiration 09-MAY-2019, Lot N000683 Expiration 06-JAN-2019.  No adverse effects were reported in any patients.  No further information was available. Additional information was requested.
Reactive arthritis caused painful swelling, bruising, and joint pain in several different joints in body. Got worse with each vaccine. After second dose it took about 4 months to get rid of pain and swelling which caused me to lose days of work, not hold my child, could barely walk/ move.  Would not wish this pain and suffering to anyone. Worse side effects seem according to several doctors. Getting the free vaccine caused me hundreds of Dollars in doctors bills due to adverse reaction.
Quarter-sized red bump and itchy on May 21. Also, hot and itchy.  May 22: Spread to two inches and blochy red. Bump and itching are gone. No meds  only benydryl cream
Information has been received from a RN concerning a 43 month old female with no known medical history or allergies who on 19Sep02 was vaccinated SC with a first dose of varicella virus vaccine live (lot642676/0421M). There was no illness at the time of vaccination. On 04May05 the pt was seen in the office with 100+ scattered varicella lesions all over her body. It was reported that the rash began in the morning. The lesions were on her face, trunk and extremities. The pt was afebrile. Unspecified medical attention was sought. No lab or diagnostic tests were performed. Treatment was reported as unk symptomatic treatment. Subsequently the pt recovered. There was no product quality complaint involved. Additional information is not expected.
Sudden decrease in vision in my right eye.  I went to the eye doctor. He said I was having a viral response in my eye. The only exposure to anything viral in the last month was the vaccine. No history of eye issues or other viral exposures.
Muffled/clogged ears like being on an airplane. Middle ear pressure that cannot be resolved by yawning, chewing or swallowing. Only improves after lying down to sleep but upon awakening, again feels like cotton is stuffed in both my ears. It has not improved since it started on 8/23/2021. No ear problem prior to the vaccine. I have not had this particular ear problem previously only transiently on the airplanes or mountainous high elevation.
Swollen Arm (Injection Site); Red and Hot Arm (Injection Site); Red and Hot Arm (Injection Site); This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE SWELLING (Swollen Arm (Injection Site)), INJECTION SITE ERYTHEMA (Red and Hot Arm (Injection Site)) and INJECTION SITE WARMTH (Red and Hot Arm (Injection Site)) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history provided).    On 03-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE SWELLING (Swollen Arm (Injection Site)), INJECTION SITE ERYTHEMA (Red and Hot Arm (Injection Site)) and INJECTION SITE WARMTH (Red and Hot Arm (Injection Site)). At the time of the report, INJECTION SITE SWELLING (Swollen Arm (Injection Site)), INJECTION SITE ERYTHEMA (Red and Hot Arm (Injection Site)) and INJECTION SITE WARMTH (Red and Hot Arm (Injection Site)) outcome was unknown.            no concomitant medication provided  no treatment taken
APPROXIMATELY 5 MINUTES AFTER ADMINISTERING VARICELLA VACCINE WHILE WAITING IN THE WAITING AREA PER PATIENTS MOTHER SHE BEGAN FACIAL SWELLING AND COUGHING.  911 CALLED, 02 ADMINISTERED 5L VIA MASK-FACIAL SWELLING NOTED UNDER R EYE WITH SLIGHT WHEEZING ON EXAM BY ARNP.  CHILD TRANSPORTED TO ER VIA AMBULANCE.
Since I got the HPV and tetanus shot I've had red circle spots appear on my right leg.
Patient states that all joints were stiff and painful when he woke up the morning after receiving the shot.  He complained of extreme pain and stiffness that lasted for several hours.  He feels much better now and has no lingering issues.
Terrible head pain and in the temples.  Dry heaves for 10 hours.  Started at 4AM in the morning, dry heaves lasting until Saturday afternoon at 5PM.  Head pains lasted until 9AM Sunday morning.  Could not take anything for pain, would not keep it down because of the dry heaves.
103.9 temp, major migraine, hard chills, severe muscle aches, diarrhea, nausea.
1 dose severe muscle pain for one day; radiating from the injection site right arm then over all muscle pain; stiffness; This is a spontaneous report from a contactable other healthcare professional (patient) reported for herself. A 41-year-old (age at vaccination) non-pregnant (at vaccination) female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiration date were not reported), via intramuscular route, administered in arm right on an unspecified date as 1st dose, single dose for covid-19 immunisation. Medical history included hypothyroid was on normal levels, had known allergies: gluten. No other vaccine received in four weeks. No COVID reported prior vaccination. Concomitant medications included quetiapine (QUETIAPINE) via an unspecified route of administration on an unspecified date at unknown dose and frequency for unknown indication; sertraline hydrochloride (SERTRALINE [SERTRALINE HYDROCHLORIDE]), via an unspecified route of administration on an unspecified date at unknown dose and frequency for unknown indication; lisdexamfetamine mesilate (VYVANSE), via an unspecified route of administration on an unspecified date at unknown dose and frequency for unknown indication; metformin, via an unspecified route of administration on an unspecified date at unknown dose and frequency for unknown indication; lamotrigine, via an unspecified route of administration on an unspecified date at unknown dose and frequency for unknown indication; and levothyroxine sodium, via an unspecified route of administration on an unspecified date at unknown dose and frequency for unknown indication. The patient previously took zolpidem and experienced known allergies. On 24May2021 at 18:00, the patient experienced 1 dose severe muscle pain for one day, radiating from the injection site right arm then over all muscle pain and stiffness. 1 dose severe muscle pain for one day, radiating from the injection site right arm then over all muscle pain and stiffness. The clinical outcome of the 1 dose severe muscle pain for one day, radiating from the injection site right arm then over all muscle pain, stiffness were recovering.   Information on the lot/batch number has been requested.
Expected arm soreness, fatigue, headache immediately or shortly after vaccination. Unexpected changes to breasts (swelling and soreness) and menstrual flow 4-14 days following vaccination.
Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Fatigue). At the time of the report, FATIGUE (Fatigue) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Concomitant product information was not provided.  AEs were not medically treated.   This case was linked to MOD-2022-476104 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 08-Feb-2022: Follow up received and contains No New Information
Friday, I had a minor sore throat, Saturday I felt fatigued, and Sunday I had sinus pressure and stuffy nose. On Monday I developed a cough and went to urgent care and tested positive after testing positive at home. Then on Tuesday I developed a lot more pressure and my breathing felt labored and fatigued and had a fever and a headache. I drank a lot of water with honey, and I took Allegra D, Zicam, Vitamin D 400 IU twice a day and some vitamin C and I took some Mucinex Monday night.
This is in follow-up to report (s) previously submitted on 5/14/2007.  Information has been received from a physician via a company representative concerning a female patient who was vaccinated IM in the left arm with a 0.5ml first (lot #6550503/0012U) and On 30-MAR-2007 with a second dose (lot #657006/0188U) of GARDASIL vaccine. There was no concomitant medication. Subsequently the patient experienced a yeast infection after each dose of the vaccination. It was noted that the patient recovered on therapy from both yeast infections. Follow-up information was received from a certified medical assitant which indicated that the patietn experienced vaginal discharge on 11-JAN-2007. Unspecified medical attention was sought. Additional information has been requested.
Patient presents to the ED on 10/18/2021 with fever, cough, diarrhea. Patient reported that she has not been feeling well over the last week with symptoms starting on 10/11. She reported that her cough has been mainly dry, fever over 100F over the last two days, nausea with ongoing diarrhea, congestion, runny nose, sore throat, fatigue, and poor appetite. She reported she went to urgent care for a COVID-19 test where she tested positive and was sent to the emergency room for an evaluation.  She reported receiving both COVID-19 vaccinations in February and March 2021.  She required oxygen up to 6L via NC during the hospitalization.  She received remdesivir, tocilizumab, and dexamethasone.  She was eventually weaned down to 2L of oxygen and discharged to a HCF.
The pt received vaccines on 12/4/01 and on 12/6/01, her parent witnessed a 30 second long episode of shaking of her entire body. This resolved spontaneously. The pt was afebrile. Dx: probable seizure.
9/24/02 telephone call from pt's mom. Reported that approximately two hours after vaccines on 9/9/02 child became pale and lethargic. She "looked through me" per mom. Axillary temperature taken-104.2 degrees, 1.875 mls Advil given every 4-6 hour for approximately 3 days. Tepid bath also given. Lack of appetite. Temperature decreased to 102 degrees after Advil but would spike back up to 104 degrees. About 40 hours after vaccines child developed bright, red, flat, hot to touch, rash on her trunk, which progressed to neck and thighs.
Alcohol withdrawal; This spontaneous case was reported by a consumer and describes the occurrence of ALCOHOL WITHDRAWAL SYNDROME (Alcohol withdrawal) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 27-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ALCOHOL WITHDRAWAL SYNDROME (Alcohol withdrawal) (seriousness criterion hospitalization). At the time of the report, ALCOHOL WITHDRAWAL SYNDROME (Alcohol withdrawal) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative (Negative) he tested negative for covid.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter.  Treatment information was not provided by the reporter.  Company comment: Although a temporal association exists, based on the current available information, the event alcohol withdrawal is assessed as unlikely related.; Sender's Comments: Although a temporal association exists, based on the current available information, the event alcohol withdrawal is assessed as unlikely related.
when i was talking to pt before admin of 2nd dose of Pfizer COVID vacc,, she mentioned she had swelling in her knuckles about one hour after the first dose (she was home already) and last week she had a rash and swollen area on the same arm that she got first dose of covid in, and there was also pain in the arm but it went away. first dose was also in right arm. about 15-20 min after 2nd dose, she stated she was having pain in arm and tingling in hands. both palms were visibly spotty. she states no prior rxn to any vaccine ever. pt gave me permission to administer PO of liquid diphenhydramine to her. she declined offer to contact resuce squad. i checked in q 5 minutes for 20 minutes. she said pain was less and hands back to normal. she again declined my offer to call rescue squad. breathing always normal. family members were with her and said they would drive her home and seek medical attention if anything else happened.
I felt very tired; Chills; Fever was 100.4; My fever is high and I am not thinking clear; Fever was 100.4; My fever is high and I am not thinking clear; This is a spontaneous report from a contactable consumer (patient) or other non hcp. A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EW0179 and expiry date: unknown), dose 1 via an unspecified route of administration on 20May2021 at 12:30 as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced I felt very tired, chills and fever was 100.4; my fever is high and i am not thinking clear on an unspecified date (The patient don't know the patient feel very "drug out" (not clarified) right now). Outcome of all the events were unknown.  Information on Lot/Batch number was available. Additional information has been requested.
Information has been received from a 64 year old female with itching and allergies to pain medications, codeine and minocycline (reported as "monocyclene") and a history of hypothyroidism who in September 2010, was vaccinated SC with 0.65 ml, single dose of ZOSTAVAX (Merck), (lot # not reported). Concomitant therapy included BENADRYL and SYNTHROID. In the beginning of November 2010 (approximately 01-NOV-2010) the patient experienced "pain where she got the shot, a rash up and down her arm, throat pain, headache and a low grade fever." "Her doctor told that her rash was the result of a pinched nerve." Azithromycin (reported as "azithromyacin") was given for the treatment of throat pain. The patient did not recover at the time of report. No lab diagnostics studies performed. The patient sought unspecified medical attention. Additional information is not expected.